article thumbnail

Public Health Product Hops

Bill of Health

Regulatory and patent exclusivity periods govern the timing of generic entry, and because market share and revenue is often quickly lost upon market entry of generic drugs, extending market exclusivity for any duration can be extremely profitable. But perhaps other forms of public health benefit would outweigh these harms?

article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

By Aparajita Lath Two articles published last month in the BMJ analyze the public investment and financing of mRNA COVID-19 vaccines, highlighting the extensive government funding that has supported the development of mRNA technology from 1985 to 2022. public investment in the development of mRNA COVID-19 vaccines between 1985 to 2019.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

InterSystems cloud integration service comes to NZ and more briefs

Healthcare It News

The French IT company was recently awarded a contract worth A$242 M ($159 million) to continue supporting the digitalisation of the WA public health system for the next five years. It has been working with HSS on the digital transformation of WA Health since 2019.

article thumbnail

France to enable rapid market access for digital therapeutics

Healthcare It News

French president Emmanuel Macron has announced plans to follow in Germany’s footsteps by making digital therapeutics available on prescription through the statutory health system. I’m very direct with you – we will just replicate what works in Germany.”

article thumbnail

Tasmania transforming outpatient services with online booking, eReferral system

Healthcare It News

The Tasmanian government has recently released a four-year strategy to transform outpatient services across its public health system. The state government has also made a A$150 million ($100 million) investment over four years to upgrade its digital health infrastructure.

article thumbnail

California Enters Insulin Manufacturing: Can We Expect to See a California Effect?

Bill of Health

have debated whether the government should produce drugs and biologics. Ultimately, the industry was successful in keeping the government away from biologics manufacturing by agreeing to abide by government regulations. By Aparajita Lath For over 100 years, policy makers and pharmaceutical manufacturers in the U.S.

article thumbnail

The Biden Administration’s Whole-of-Government Approach to Equity – in Health and Beyond

Health Populi

Here’s a key detail in the fine print of the Executive Order on Advancing Racial Equity and Support for Underserved Communities Through the Federal Government: “ Equal opportunity is the bedrock of American democracy, and our diversity is one of our country’s greatest strengths. But for too many, the American Dream remains out of reach.